170
Participants
Start Date
June 1, 2017
Primary Completion Date
February 2, 2023
Study Completion Date
January 19, 2024
Vitamin K antagonist or direct oral anticoagulant treatment
"The Vitamin K antagonist or direct oral anticoagulant treatment will be administered to obtain an International Normalized Ratio between 2 and 3 as recommended if the treatment is AVK.~The Direct oral anticoagulant treatment : Apixaban 5 mg x2 or 2.5 mg X2, Edoxaban 30 ou 60 mg"
Aspirin
"Daily dose is between 75 mg and 100 mg.~Allergic reactions to aspirin may be observed in rare cases. In case of suspicion of allergy, treatment with aspirin is stopped."
CHRU de Nîmes - Hôpital Universitaire Carémeau, Nîmes
Hôpital Privé les Franciscaines, Nîmes
CHRU de Montpellier - Hôpital Arnaud de Villeneuve, Montpellier
Clinique du Millénaire, Montpellier
Clinique Saint-Pierre, Perpignan
CH de Perpignan - Hôpital Saint Jean, Perpignan
Collaborators (1)
Medtronic
INDUSTRY
Centre Hospitalier Universitaire de Nīmes
OTHER